Preparing COVID-19 Vaccine Moderna at PCN Designated Sites

Sue Dickinson, Director of Pharmacy, Regional Drug & Therapeutics Centre (Newcastle)Published Last updated See all updates

Standard Operating Procedures for preparation of the Moderna Spikevax® COVID-19 Vaccine in PCN designated sites prior to immediate administration.

Information

Two different doses of the Moderna Spikevax® vaccine are used depending whether administration is either part of a primary immunisation course or being used as a booster.

Separate procedures and work instructions are now available for both the 0.5ml primary course and the 0.25ml booster dose.

Local systems must be in place to ensure that staff undertaking preparation have confirmed which dose is required and that only the correct dose specific supporting documents are in use during the preparation of the syringe for administration.

Standard operating procedures for each dose are attached to this page.

Within a SOP:

  • GREEN TEXT indicates that detail is awaited and will be added when available
  • RED TEXT indicates where detail is to be added locally

You should also familiarise yourself with our background guide Facilitating Pharmaceutical support to PCN Designated Sites for COVID-19 vaccinations before using these SOPs

These documents may be adapted by Superintendent Pharmacists for the use of the vaccine in community pharmacy settings

Attachments

Other handling content for PCNs

Other COVID-19 vaccines resources

Change history

  1. Current content remains accurate
  1. Current content remains accurate
  1. MVH 3b Section 7 corrected supporting dose work instruction reference to MVH 3.1b
  1. MVH 3 renamed MVH 3a and updated to highlight this procedure is specific to the 0.5ml primary course dose. Added check that correct dose is being prepared and further advice to reduce risk of coring.
  2. MVH 3.1 renamed MVH 3.1a and updated to highlight this instruction is specific to the 0.5ml primary course dose. Added check that correct dose is being prepared and further advice to reduce risk of coring.
  3. MVH 3.2 updated to include both primary course and booster dose information
  4. MVH 3b and MVH 3.1b uploaded as new documents specific to the 0.25ml booster dose
  1. MVH3 Section 5.4.2 removal of outdated Foundry codes
  2. MVH3 Section 5.2.3 Amended reference to storage up to 25 degrees C to reflect extended time of 24 hours
  3. MVH 3 3.1 and 3,2 the name of the vaccine has changed to Spikevax®
  1. MVH3 Section 5.3.1 amended to allow 11 doses to be withdrawn from each vial
  2. MVH3.1 renumbered
  1. Published